Skip to main content
Top
Published in: BMC Medical Genetics 1/2014

Open Access 01-12-2014 | Case report

A large de novo9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma

Authors: Simona Frigerio, Vittoria Disciglio, Siranoush Manoukian, Bernard Peissel, Gabriella Della Torre, Andrea Maurichi, Paola Collini, Barbara Pasini, Giacomo Gotti, Andrea Ferrari, Licia Rivoltini, Maura Massimino, Monica Rodolfo

Published in: BMC Medical Genetics | Issue 1/2014

Login to get access

Abstract

Background

Association of melanoma, neural system tumors and germ line mutations at the 9p21 region in the CDKN2A, CDKN2B and CDKN2BAS genes has been reported in a small number of families worldwide and described as a discrete syndrome in melanoma families registered as a rare disease, the melanoma–astrocytoma syndrome.

Case presentation

We here studied two young patients developing melanoma after radiotherapy for astrocytoma, both reporting lack of family history for melanoma or neural system tumors at genetic counselling. Patient A is a girl treated for anaplastic astrocytoma at 10 years and for multiple melanomas on the scalp associated to dysplastic nevi two years later. Her monozygotic twin sister carried dysplastic nevi and a slow growing, untreated cerebral lesion. Direct sequencing analysis showed no alterations in melanoma susceptibility genes including CDKN2A, CDK4, MC1R and MITF or in TP53. By microsatellite analysis, multiplex ligation-dependent probe amplification, and array comparative genomic hybridization a deletion including the CDKN2A, CDKN2B and CDKN2BAS gene cluster was detected in both twin sisters, encompassing a large region at 9p21.3 and occurring de novo after the loss of one paternal allele.
Patient B is a boy of 7 years when treated for astrocytoma then developing melanoma associated to congenital nevi on the head 10 years later: sequencing and multiplex ligation-dependent probe amplification revealed a normal profile of the CDKN2A/CDKN2B/CDKN2BAS region. Array comparative genomic hybridization confirmed the absence of deletions at 9p21.3 and failed to reveal known pathogenic copy number variations.

Conclusions

By comparison with the other germ line deletions at the CDKN2A, CDKN2B and CDKN2BAS gene cluster reported in melanoma susceptible families, the deletion detected in the two sisters is peculiar for its de novo origin and for its extension, as it represents the largest constitutive deletion at 9p21.3 region identified so far.
In addition, the two studied cases add to other evidence indicating association of melanoma with exposure to ionizing radiation and with second neoplasm after childhood cancer. Melanoma should be considered in the monitoring of pigmented lesions in young cancer patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M: Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumours. Cancer Res. 1998, 58: 2298-2303.PubMed Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M: Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumours. Cancer Res. 1998, 58: 2298-2303.PubMed
2.
go back to reference Randerson-Moor J, Kukalizch K, Bishop TD: Melanoma-Astrocytoma syndrome. Atlas Genet Cytogenet Oncol Haematol. 2006, 10: 288-291. Randerson-Moor J, Kukalizch K, Bishop TD: Melanoma-Astrocytoma syndrome. Atlas Genet Cytogenet Oncol Haematol. 2006, 10: 288-291.
3.
go back to reference Pasmant E, Laurendeau I, Héron D, Vidaud M, Vidaud D, Bièche I: Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007, 67: 3963-3969. 10.1158/0008-5472.CAN-06-2004.CrossRefPubMed Pasmant E, Laurendeau I, Héron D, Vidaud M, Vidaud D, Bièche I: Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 2007, 67: 3963-3969. 10.1158/0008-5472.CAN-06-2004.CrossRefPubMed
4.
go back to reference Nielsen K, Ingvar C, Måsbäck A, Westerdahl J, Borg A, Sandberg T, Jonsson N, Nagel J, Olsson H: Melanoma and nonmelanoma skin cancer in patients with multiple tumours–evidence for new syndromes in a population-based study. Br J Dermatol. 2004, 150: 531-536. 10.1111/j.1365-2133.2003.05852.x.CrossRefPubMed Nielsen K, Ingvar C, Måsbäck A, Westerdahl J, Borg A, Sandberg T, Jonsson N, Nagel J, Olsson H: Melanoma and nonmelanoma skin cancer in patients with multiple tumours–evidence for new syndromes in a population-based study. Br J Dermatol. 2004, 150: 531-536. 10.1111/j.1365-2133.2003.05852.x.CrossRefPubMed
5.
go back to reference Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-de Paillerets B, Azizi E: Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours. Br J Cancer. 2005, 92: 2278-2285. 10.1038/sj.bjc.6602629.CrossRefPubMedPubMedCentral Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-de Paillerets B, Azizi E: Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours. Br J Cancer. 2005, 92: 2278-2285. 10.1038/sj.bjc.6602629.CrossRefPubMedPubMedCentral
6.
go back to reference Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, et al: High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006, 66: 9818-9828. 10.1158/0008-5472.CAN-06-0494.CrossRefPubMed Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, et al: High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006, 66: 9818-9828. 10.1158/0008-5472.CAN-06-0494.CrossRefPubMed
7.
go back to reference Solomon DA, Kim JS, Yang XR, Tucker MA, Goldstein AM, Samuels Y, Waldman T: Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome. Pigment Cell Melanoma Res. 2009, 22: 489-491. 10.1111/j.1755-148X.2009.00587.x.CrossRefPubMedPubMedCentral Solomon DA, Kim JS, Yang XR, Tucker MA, Goldstein AM, Samuels Y, Waldman T: Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome. Pigment Cell Melanoma Res. 2009, 22: 489-491. 10.1111/j.1755-148X.2009.00587.x.CrossRefPubMedPubMedCentral
8.
go back to reference Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group: Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet. 2006, 43: 39-47. 10.1136/jmg.2005.038398.CrossRefPubMed Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B, French Hereditary Melanoma Study Group: Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Genet. 2006, 43: 39-47. 10.1136/jmg.2005.038398.CrossRefPubMed
9.
go back to reference Ghiorzo P, Gargiulo S, Pastorino L, Nasti S, Cusano R, Bruno W, Gliori S, Sertoli MR, Burroni A, Savarino V, Gensini F, Sestini R, Queirolo P, Goldstein AM, Scarrà GB: Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. Hum Mol Genet. 2006, 15: 2682-2689. 10.1093/hmg/ddl199.CrossRefPubMed Ghiorzo P, Gargiulo S, Pastorino L, Nasti S, Cusano R, Bruno W, Gliori S, Sertoli MR, Burroni A, Savarino V, Gensini F, Sestini R, Queirolo P, Goldstein AM, Scarrà GB: Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. Hum Mol Genet. 2006, 15: 2682-2689. 10.1093/hmg/ddl199.CrossRefPubMed
10.
go back to reference Lesueur F, de Lichy M, Barrois M, Durand G, Bombled J, Avril MF, Chompret A, Boitier F, Lenoir GM, Bressac-de Paillerets B, Baccard M, Bachollet B, Berthet P, Bonadona V, Bonnetblanc JM, Caron O, Chevrant-Breton J, Cuny JF, Dalle S, Delaunay M, Demange L, De Quatrebarbes J, Doré JF, Frénay M, Fricker JP, Gauthier-Villars M, Gesta P, Giraud S, Gorry P, French Familial Melanoma Study Group, et al: The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. Br J Cancer. 2008, 99: 364-370. 10.1038/sj.bjc.6604470.CrossRefPubMedPubMedCentral Lesueur F, de Lichy M, Barrois M, Durand G, Bombled J, Avril MF, Chompret A, Boitier F, Lenoir GM, Bressac-de Paillerets B, Baccard M, Bachollet B, Berthet P, Bonadona V, Bonnetblanc JM, Caron O, Chevrant-Breton J, Cuny JF, Dalle S, Delaunay M, Demange L, De Quatrebarbes J, Doré JF, Frénay M, Fricker JP, Gauthier-Villars M, Gesta P, Giraud S, Gorry P, French Familial Melanoma Study Group, et al: The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma. Br J Cancer. 2008, 99: 364-370. 10.1038/sj.bjc.6604470.CrossRefPubMedPubMedCentral
11.
go back to reference Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S, Bondy ML, Melin BS, The Gliogene Consortium: Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014, in press Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S, Bondy ML, Melin BS, The Gliogene Consortium: Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014, in press
12.
go back to reference Hill VK1, Gartner JJ, Samuels Y, Goldstein AM: The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet. 2013, 14: 257-279. 10.1146/annurev-genom-091212-153429.CrossRefPubMed Hill VK1, Gartner JJ, Samuels Y, Goldstein AM: The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet. 2013, 14: 257-279. 10.1146/annurev-genom-091212-153429.CrossRefPubMed
13.
go back to reference Daniotti M, Ferrari A, Frigerio S, Casieri P, Miselli F, Zucca E, Collini P, Della Torre G, Manoukian S, Peissel B, Bono A, Santinami M, Parmiani G, Rivoltini L, Pilotti S, Rodolfo M: Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. J Invest Dermatol. 2009, 129: 1759-1768. 10.1038/jid.2008.422.CrossRefPubMed Daniotti M, Ferrari A, Frigerio S, Casieri P, Miselli F, Zucca E, Collini P, Della Torre G, Manoukian S, Peissel B, Bono A, Santinami M, Parmiani G, Rivoltini L, Pilotti S, Rodolfo M: Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT. J Invest Dermatol. 2009, 129: 1759-1768. 10.1038/jid.2008.422.CrossRefPubMed
14.
go back to reference Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, Taylor JC, Duffy DL, Holohan K, Dutton-Regester K, Palmer JM, Bonazzi V, Stark MS, Symmons J, Law MH, Schmidt C, Lanagan C, O’Connor L, Holland EA, Schmid H, Maskiell JA, Jetann J, Ferguson M, Jenkins MA, Kefford RF, Giles GG, et al: A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 2011, 480: 99-103. 10.1038/nature10630.CrossRefPubMedPubMedCentral Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, Taylor JC, Duffy DL, Holohan K, Dutton-Regester K, Palmer JM, Bonazzi V, Stark MS, Symmons J, Law MH, Schmidt C, Lanagan C, O’Connor L, Holland EA, Schmid H, Maskiell JA, Jetann J, Ferguson M, Jenkins MA, Kefford RF, Giles GG, et al: A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 2011, 480: 99-103. 10.1038/nature10630.CrossRefPubMedPubMedCentral
15.
go back to reference Ghiorzo P, Pastorino L, Queirolo P, Bruno W, Tibiletti MG, Nasti S, Andreotti V, Paillerets BB, Bianchi Scarrà G, Genoa Pancreatic Cancer Study Group: Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res. 2013, 26: 259-262. 10.1111/pcmr.12047.CrossRefPubMed Ghiorzo P, Pastorino L, Queirolo P, Bruno W, Tibiletti MG, Nasti S, Andreotti V, Paillerets BB, Bianchi Scarrà G, Genoa Pancreatic Cancer Study Group: Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. Pigment Cell Melanoma Res. 2013, 26: 259-262. 10.1111/pcmr.12047.CrossRefPubMed
16.
go back to reference Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT: Prevalence of 9p21 deletions in UK melanoma families. Genes Chromosomes Cancer. 2005, 44: 292-300. 10.1002/gcc.20238.CrossRefPubMed Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT: Prevalence of 9p21 deletions in UK melanoma families. Genes Chromosomes Cancer. 2005, 44: 292-300. 10.1002/gcc.20238.CrossRefPubMed
17.
go back to reference Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT: A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Molec Genet. 2001, 10: 55-62. 10.1093/hmg/10.1.55.CrossRefPubMed Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN, Bishop DT: A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Molec Genet. 2001, 10: 55-62. 10.1093/hmg/10.1.55.CrossRefPubMed
18.
go back to reference Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lønning PE: A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family. Genes Chromosomes Cancer. 2006, 45: 1155-1163. 10.1002/gcc.20379.CrossRefPubMed Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lønning PE: A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family. Genes Chromosomes Cancer. 2006, 45: 1155-1163. 10.1002/gcc.20379.CrossRefPubMed
19.
go back to reference Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, De-Paillerets BB: Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer. 2007, 121: 825-831. 10.1002/ijc.22712.CrossRefPubMed Goldstein AM, Chaudru V, Ghiorzo P, Badenas C, Malvehy J, Pastorino L, Laud K, Hulley B, Avril MF, Puig-Butille JA, Miniere A, Marti R, Chompret A, Cuellar F, Kolm I, Mila M, Tucker MA, Demenais F, Bianchi-Scarra G, Puig S, De-Paillerets BB: Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer. 2007, 121: 825-831. 10.1002/ijc.22712.CrossRefPubMed
20.
go back to reference Hayward NK: Genetics of melanoma predisposition. Oncogene. 2003, 22: 3053-3062. 10.1038/sj.onc.1206445.CrossRefPubMed Hayward NK: Genetics of melanoma predisposition. Oncogene. 2003, 22: 3053-3062. 10.1038/sj.onc.1206445.CrossRefPubMed
21.
go back to reference Aguilo F, Zhou MM, Walsh MJ: Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 2011, 71: 5365-5369. 10.1158/0008-5472.CAN-10-4379.CrossRefPubMedPubMedCentral Aguilo F, Zhou MM, Walsh MJ: Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 2011, 71: 5365-5369. 10.1158/0008-5472.CAN-10-4379.CrossRefPubMedPubMedCentral
22.
go back to reference Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, et al: Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012, 131: 1877-1888. 10.1007/s00439-012-1212-0.CrossRefPubMedPubMedCentral Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, et al: Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012, 131: 1877-1888. 10.1007/s00439-012-1212-0.CrossRefPubMedPubMedCentral
23.
go back to reference Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin-A-Woeng T, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubiński J, et al: Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet. 2009, 41: 920-925. 10.1038/ng.411.CrossRefPubMedPubMedCentral Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin-A-Woeng T, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubiński J, et al: Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet. 2009, 41: 920-925. 10.1038/ng.411.CrossRefPubMedPubMedCentral
24.
go back to reference Pasmant E, Sabbagh A, Vidaud M, Bièche I: ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011, 25: 444-448. 10.1096/fj.10-172452.CrossRefPubMed Pasmant E, Sabbagh A, Vidaud M, Bièche I: ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011, 25: 444-448. 10.1096/fj.10-172452.CrossRefPubMed
25.
go back to reference Brockschmidt A, Trost D, Peterziel H, Zimmermann K, Ehrler M, Grassmann H, Pfenning PN, Waha A, Wohlleber D, Brockschmidt FF, Jugold M, Hoischen A, Kalla C, Waha A, Seifert G, Knolle PA, Latz E, Hans VH, Wick W, Pfeifer A, Angel P, Weber RG: KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas. Brain. 2012, 135: 1027-1041. 10.1093/brain/aws045.CrossRefPubMed Brockschmidt A, Trost D, Peterziel H, Zimmermann K, Ehrler M, Grassmann H, Pfenning PN, Waha A, Wohlleber D, Brockschmidt FF, Jugold M, Hoischen A, Kalla C, Waha A, Seifert G, Knolle PA, Latz E, Hans VH, Wick W, Pfeifer A, Angel P, Weber RG: KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas. Brain. 2012, 135: 1027-1041. 10.1093/brain/aws045.CrossRefPubMed
26.
go back to reference Cai Z1, Wang Y, Yu W, Xiao J, Li Y, Liu L, Zhu C, Tan K, Deng Y, Yuan W, Liu M, Wu X: HNULP1, a basic helix-loop-helix protein with a novel transcriptional repressive domain, inhibits transcriptional activity of serum response factor. Biochem Biophys Res Commun. 2006, 343: 973-981. 10.1016/j.bbrc.2006.02.187.CrossRefPubMed Cai Z1, Wang Y, Yu W, Xiao J, Li Y, Liu L, Zhu C, Tan K, Deng Y, Yuan W, Liu M, Wu X: HNULP1, a basic helix-loop-helix protein with a novel transcriptional repressive domain, inhibits transcriptional activity of serum response factor. Biochem Biophys Res Commun. 2006, 343: 973-981. 10.1016/j.bbrc.2006.02.187.CrossRefPubMed
27.
go back to reference Lyng H1, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T: Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics. 2006, 7: 268-10.1186/1471-2164-7-268.CrossRefPubMedPubMedCentral Lyng H1, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T: Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics. 2006, 7: 268-10.1186/1471-2164-7-268.CrossRefPubMedPubMedCentral
28.
go back to reference Guérin S, Dupuy A, Anderson H, Shamsaldin A, Svahn-Tapper G, Moller T, Quiniou E, Garwicz S, Hawkins M, Avril MF, Oberlin O, Chavaudra J, de Vathaire F: Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer. 2003, 39: 2379-2786. 10.1016/S0959-8049(03)00663-4.CrossRefPubMed Guérin S, Dupuy A, Anderson H, Shamsaldin A, Svahn-Tapper G, Moller T, Quiniou E, Garwicz S, Hawkins M, Avril MF, Oberlin O, Chavaudra J, de Vathaire F: Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer. 2003, 39: 2379-2786. 10.1016/S0959-8049(03)00663-4.CrossRefPubMed
29.
go back to reference Eliason MJ, Hansen CB, Hart M, Porter-Gill P, Chen W, Sturm RA, Bowen G, Florell SR, Harris RM, Cannon-Albright LA, Swinyer L, Leachman SA: Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol. 2007, 143: 1409-1412.CrossRefPubMed Eliason MJ, Hansen CB, Hart M, Porter-Gill P, Chen W, Sturm RA, Bowen G, Florell SR, Harris RM, Cannon-Albright LA, Swinyer L, Leachman SA: Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol. 2007, 143: 1409-1412.CrossRefPubMed
30.
go back to reference Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D: Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants. Arch Dermatol. 2007, 143: 495-499.CrossRefPubMed Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D: Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants. Arch Dermatol. 2007, 143: 495-499.CrossRefPubMed
31.
go back to reference Haddy N, Mousannif A, Paoletti C, Dondon MG, Shamsaldin A, Doyon F, Avril MF, Fragu P, Labbé M, Lefkopoulos D, Chavaudra J, Robert C, Diallo I, de Vathaire F: Radiotherapy as a risk factor for malignant melanoma after childhood skin hemangioma. Melanoma Res. 2012, 22: 77-85. 10.1097/CMR.0b013e32834dcff1.CrossRefPubMed Haddy N, Mousannif A, Paoletti C, Dondon MG, Shamsaldin A, Doyon F, Avril MF, Fragu P, Labbé M, Lefkopoulos D, Chavaudra J, Robert C, Diallo I, de Vathaire F: Radiotherapy as a risk factor for malignant melanoma after childhood skin hemangioma. Melanoma Res. 2012, 22: 77-85. 10.1097/CMR.0b013e32834dcff1.CrossRefPubMed
32.
go back to reference Sturiale CL, Sabatino G, Albanese A, Balducci M, Lauriola L, Pennacchia I, Maira G: Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma. J Neurooncol. 2012, 106: 203-207. 10.1007/s11060-011-0646-x.CrossRefPubMed Sturiale CL, Sabatino G, Albanese A, Balducci M, Lauriola L, Pennacchia I, Maira G: Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma. J Neurooncol. 2012, 106: 203-207. 10.1007/s11060-011-0646-x.CrossRefPubMed
33.
go back to reference Braam KI, Overbeek A, Kaspers GJ, Ronckers CM, Schouten-van Meeteren AY, Van Dulmen-Den Broeder E, Veening MA: Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: A systematic review. Pediatr Blood Cancer. 2012, 58: 665-674. 10.1002/pbc.24023.CrossRefPubMed Braam KI, Overbeek A, Kaspers GJ, Ronckers CM, Schouten-van Meeteren AY, Van Dulmen-Den Broeder E, Veening MA: Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: A systematic review. Pediatr Blood Cancer. 2012, 58: 665-674. 10.1002/pbc.24023.CrossRefPubMed
34.
go back to reference Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, Hammond S, Stovall M, Neglia JP, Robison LL: Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study. Pediatr Blood Cancer. 2013, 60: 461-466. 10.1002/pbc.24266.CrossRefPubMed Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, Hammond S, Stovall M, Neglia JP, Robison LL: Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: A report from the childhood cancer survivor study. Pediatr Blood Cancer. 2013, 60: 461-466. 10.1002/pbc.24266.CrossRefPubMed
35.
go back to reference Haliasos HC, Zalaudek I, Malvehy J, Lanschuetzer C, Hinter H, Hofmann-Wellenhof R, Braun R, Marghoob AA: Dermoscopy of benign and malignant neoplasms in the pediatric population. Semin Cutan Med Surg. 2010, 29: 218-231. 10.1016/j.sder.2010.10.003.CrossRefPubMed Haliasos HC, Zalaudek I, Malvehy J, Lanschuetzer C, Hinter H, Hofmann-Wellenhof R, Braun R, Marghoob AA: Dermoscopy of benign and malignant neoplasms in the pediatric population. Semin Cutan Med Surg. 2010, 29: 218-231. 10.1016/j.sder.2010.10.003.CrossRefPubMed
Metadata
Title
A large de novo9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma
Authors
Simona Frigerio
Vittoria Disciglio
Siranoush Manoukian
Bernard Peissel
Gabriella Della Torre
Andrea Maurichi
Paola Collini
Barbara Pasini
Giacomo Gotti
Andrea Ferrari
Licia Rivoltini
Maura Massimino
Monica Rodolfo
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2014
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-15-59

Other articles of this Issue 1/2014

BMC Medical Genetics 1/2014 Go to the issue